Clinical Trials Browser

Head and Neck Neoplasms, Laryngeal Diseases

Breast Neoplasms, Colonic Neoplasms, Sarcoma, Cholangiocarcinoma

Advanced Solid Tumors

Carcinoma, Non-Small-Cell Lung

Advanced Solid Tumors

Mesothelioma, Malignant

Cholangiocarcinoma

Uterine Cervical Neoplasms, Vaginal Neoplasms, Carcinoma, Endometrioid

Esophageal Neoplasms, Head and Neck Neoplasms, Stomach Neoplasms

Carcinoma, Non-Small-Cell Lung

Adenocarcinoma of Lung, Osteosarcoma

Carcinoma, Non-Small-Cell Lung

Mesothelioma

Gastric Adenocarcinoma

Small Cell Lung Carcinoma

Small Cell Lung Carcinoma

Biliary Tract Neoplasms, Neoplasm Metastasis

Neoplasm Metastasis

Mesothelioma, Malignant, Mesothelioma

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms

Squamous Cell Carcinoma of Head and Neck, Carcinoma

Melanoma, Neoplasm Metastasis

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Biliary Tract Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Adult Solid Neoplasm

Carcinoma, Non-Small-Cell Lung

Small Cell Lung Carcinoma

Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis

Esophageal Neoplasms, Lung Neoplasms, Pancreatic Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Osteosarcoma

Unspecified Adult Solid Tumor, Protocol Specific

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Pancreatic Neoplasms

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung

Squamous Cell Carcinoma of Head and Neck

Carcinoma, Non-Small-Cell Lung

Uterine Cervical Neoplasms

Clinical Trials

Phase 1b Safety Study of Xevinapant, Weekly Cisplatin, and RT in Participants With Unresected LA SCCHN (HyperlynX)

A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors

A Phase I Clinical Study for Evaluating the Safety and Efficacy of MASCT-I in Patients With Advanced Solid Tumors

Induction

Study to Assess the Effects of GS-3583 in Participants With Advanced Solid Tumors

A Pilot Window-Of-Opportunity Study of the Anti-PD-1 Antibody Pembrolizumab in Patients With Resectable Malignant Pleural Mesothelioma

Gemcitabine and Cisplatin With Ivosidenib or Pemigatinib for the Treatment of Unresectable or Metastatic Cholangiocarcinoma

Testing AZD1775 inC Combination With Radiotherapy and Chemotherapy in Cervical, Upper Vaginal and Uterine Cancers

A Dose Escalation Study of Adavosertib(MK1775) in Combination With 5-FU or 5-FU/CDDP in Patients With Advanced Solid Tumor (1775-005

Neoadjuvant Chemoradiation Plus Pembrolizumab Followed By Consolidation Pembrolizumab in NSCLC

IBI188 Combination Therapy in Solid Tumors

PDR001 in Combination With Platinum-doublet Chemotherapy and Other Immunology Agents in PD-L1 Unselected, Metastatic NSCLC Patients

Study of Cytoreductive Surgery and Hyperthermic Intraoperative Chemotherapy With Pemetrexed and Cisplatin for MPM

Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Anti-Cancer Agents in Japanese Participants With Gastric or Gastroesophageal Junction Adenocarcinoma

Phase Ib/II Study of M3814 With Etoposide and Cisplatin in Small Cell Lung Cancer (SCLC) Extensive Disease (ED)

A Study of Rovalpituzumab Tesirine (SC16LD6.5) in the Frontline Treatment of Patients With Extensive Stage Small Cell Lung Cancer

BIBW 2992 as add-on to Gem/Cis in Advanced Biliary Tract Cancer

A Safety Study in Participants With Advanced Solid Tumors

SS1(dsFV)PE38 Plus Pemetrexed and Cisplatin to Treat Malignant Pleural Mesothelioma

Azacitidine and Cisplatin in Patients With Advanced Lung or Head and Neck Cancer

Ficlatuzumab, Cisplatin and IMRT in Locally Advanced Head and Neck Squamous Cell Carcinoma

IPI Biochemotherapy for Chemonaive Patients With Metastatic Melanoma

Cancer Immunotherapy GSK1572932A as Adjuvant Therapy for Patients With Tumor-antigen-positive Non-Small Cell Lung Cancer

Sym004 in Subjects With Stage IV Non-small Cell Lung Cancer

Selumetinib (AZD6244, ARRY-142886) J-BTC Phase 1 Study

Proton Radiation Therapy With Cisplatin and Etoposide Followed by Surgery in Stage III Non-Small Cell Lung Cancer

Calcitriol, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors That Cannot Be Removed by Surgery

HALO

Determination of Safety, Efficacy, and Pharmacokinetics of "Regorafenib" Combined With Pemetrexed and Cisplatin in Patients With Nonsquamous Non-Small Cell Lung Cancer

EMD 1201081 + 5-FU + Cisplatin + Cetuximab in Subjects With Recurrent / Metastatic Squamous Cell Carcinoma of the Head and Neck

Safety of AMG 706 Plus Panitumumab Plus Gemcitabine-Cisplatin in the Treatment of Patients With Advanced Cancer

A Dose Ascending Study of Gemcitabine Elaidate (CO-101) in Combination With Cisplatin

A Study of TS-1, Cisplatin (CDDP) and RAD001 (Everolimus)

A Study of Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of Response

7-hydroxystaurosporine and Cisplatin in Treating Patients With Advanced Malignant Solid Tumors

Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung Cancer

RAD001 With Weekly Cisplatin and Radiation Therapy in Patients With Locally Advanced Head and Neck Cancer

Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung Cancer

Gefitinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer

CisPemXetSrg

Efficacy Study of Weekly Topotecan With Cisplatin in Advanced Stage or Recurrent Cervical Cancer